Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells
- PMID: 12479367
Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells (V体育安卓版)
Abstract
To evaluate the role of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway in breast cancer cell survival and therapeutic resistance, we analyzed a panel of six breast cancer cell lines that varied in erbB2 and estrogen receptor status. Akt activity was constitutive in four cell lines and was associated with either PTEN mutations or erbB2 overexpression. Akt promoted breast cancer cell survival because a PI3K inhibitor, LY294002, or transient transfection of a dominant-negative Akt mutant inhibited Akt activity and increased apoptosis. When combined with therapies commonly used in breast cancer treatment, LY294002 potentiated apoptosis caused by doxorubicin, trastuzumab, paclitaxel, or etoposide. Potentiation of apoptosis by LY294002 correlated with induction of Akt by doxorubicin or trastuzumab alone that occurred before the onset of apoptosis. Similar results were observed with tamoxifen. Combining LY294002 with tamoxifen in estrogen receptor-positive cells greatly potentiated apoptosis, which was correlated with tamoxifen-induced Akt phosphorylation that preceded apoptosis. To confirm that the effects of LY294002 on chemotherapy-induced apoptosis were attributable to inhibition of Akt, we transiently transfected breast cancer cells with dominant-negative Akt and observed increased doxorubicin-induced apoptosis VSports手机版. Conversely, stably transfecting cells with constitutively active Akt increased Akt activity and attenuated doxorubicin-induced apoptosis. These studies show that endogenous Akt activity promotes breast cancer cell survival and therapeutic resistance, and that induction of Akt by chemotherapy, trastuzumab, or tamoxifen might be an early compensatory mechanism that could be exploited to increase the efficacy of these therapies. .
Comment in (VSports app下载)
-
Starting with the ABCs: Akt in breast cancer.Mol Cancer Ther. 2011 Nov;10(11):2031. doi: 10.1158/1535-7163.MCT-11-0712. Mol Cancer Ther. 2011. PMID: 22072813 No abstract available.
MeSH terms (VSports手机版)
- "VSports在线直播" Actions
- Actions (VSports app下载)
- VSports注册入口 - Actions
- "VSports app下载" Actions
- "V体育平台登录" Actions
- Actions (V体育安卓版)
- Actions (V体育官网入口)
- Actions (VSports app下载)
- "V体育2025版" Actions
- "V体育ios版" Actions
- V体育官网 - Actions
Substances
- VSports - Actions
- "VSports手机版" Actions
- VSports注册入口 - Actions
- V体育官网 - Actions
- Actions (VSports手机版)
- V体育安卓版 - Actions
- "V体育官网" Actions
- V体育官网入口 - Actions
LinkOut - more resources
Other Literature Sources
"VSports最新版本" Medical
Research Materials
Miscellaneous